EFFECTOR Therapeutics to Participate in Upcoming Investor Conference

SOLANA BEACH, Calif. and REDWOOD CITY, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitor

GlobeNewswireApr 9 20:00

Analysts Offer Insights on Healthcare Companies: Marinus (MRNS), UniQure (QURE) and EFFECTOR Therapeutics (EFTR)

TipRanksApr 9 10:20

Analysts Offer Insights on Healthcare Companies: EFFECTOR Therapeutics (EFTR), Adagene (ADAG) and Aquestive Therapeutics (AQST)

TipRanksApr 5 18:30

Trending Stocks Today: Candel Therapeutics Surges 121.64%

April 4th - US stocks trending in regular trading hours.Gainers: $Candel Therapeutics(CADL.US)$ surges 121.64% to $3.72 with a turnover of $214.01 million. $Allurion Technologies(ALUR.US)$ soars 92.48

Futu NewsApr 5 02:00

Top Midday Decliners

eFFECTOR Therapeutics (EFTR) Chief Executive Officer Steve Worland said there is no "obvious path forward to continue developing tomivosertib in frontline NSCLC" based on the data currently available

MT NewswiresApr 5 01:54

Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of STAAR Surgical Company (NASDAQ:STAA) rose sharply during Thursday's session after the company issued strong preliminary first-quarter net sales guidance. STAAR Surgical shares jumped 13.3%

BenzingaApr 5 01:21